Frankfurt, Germany

Irena Pulte

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merz Pharma Gmbh & Co. Kgaa. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irena Pulte. Retrieved from https://idiyas.com/inventor/irena-pulte-ny4rwqf8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Irena Pulte: Innovator in Medical Treatments

Introduction

Irena Pulte is a notable inventor based in Frankfurt, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of sialorrhea. Her innovative approach has garnered attention in the medical community.

Latest Patents

Irena holds a patent for the "Use of Botulinum Neurotoxin in the Treatment of Sialorrhea." This patent represents her commitment to advancing medical treatments and improving patient care. She has successfully developed a method that utilizes botulinum neurotoxin to alleviate excessive salivation, a condition that can significantly impact quality of life.

Career Highlights

Irena Pulte is currently associated with Merz Pharma GmbH & Co. KGaA, a company known for its focus on innovative healthcare solutions. Her work at Merz Pharma has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Irena has worked alongside talented colleagues such as Michael Althaus and Nico Wegener. Their combined expertise has fostered an environment of innovation and collaboration, leading to advancements in medical treatments.

Conclusion

Irena Pulte's contributions to the field of medicine through her patent and work at Merz Pharma highlight her role as a pioneering inventor. Her dedication to improving patient outcomes through innovative treatments is commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…